Genome-wide transcriptome profiling of human trabecular meshwork cells treated with TGF-β2

Breedge Callaghan, Karen Lester, Brian Lane, Xiaochen Fan, Katarzyna Goljanek-Whysall, David A. Simpson, Carl Sheridan, Colin E. Willoughby

    Research output: Contribution to journalArticlepeer-review

    3 Downloads (Pure)

    Abstract

    Glaucoma is a complex neurodegenerative disease resulting in progressive optic neuropathy and is a leading cause of irreversible blindness worldwide. Primary open angle glaucoma (POAG) is the predominant form affecting 65.5 million people globally. Despite the prevalence of POAG and the identification of over 120 glaucoma related genetic loci, the underlaying molecular mechanisms are still poorly understood. The transforming growth factor beta (TGF-β) signalling pathway is implicated in the molecular pathology of POAG. To gain a better understanding of the role TGF-β2 plays in the glaucomatous changes to the molecular pathology in the trabecular meshwork, we employed RNA-Seq to delineate the TGF-β2 induced changes in the transcriptome of normal primary human trabecular meshwork cells (HTM). We identified a significant number of differentially expressed genes and associated pathways that contribute to the pathogenesis of POAG. The differentially expressed genes were predominantly enriched in ECM regulation, TGF-β signalling, proliferation/apoptosis, inflammation/wound healing, MAPK signalling, oxidative stress and RHO signalling. Canonical pathway analysis confirmed the enrichment of RhoA signalling, inflammatory-related processes, ECM and cytoskeletal organisation in HTM cells in response to TGF-β2. We also identified novel genes and pathways that were affected after TGF-β2 treatment in the HTM, suggesting additional pathways are activated, including Nrf2, PI3K-Akt, MAPK and HIPPO signalling pathways. The identification and characterisation of TGF-β2 dependent differentially expressed genes and pathways in HTM cells is essential to understand the patho-physiology of glaucoma and to develop new therapeutic agents.

    Original languageEnglish
    Article number9564
    Number of pages12
    JournalScientific Reports
    Volume12
    Issue number1
    DOIs
    Publication statusPublished - 10 Jun 2022

    Bibliographical note

    Funding: Glaucoma UK, Fight for Sight (UK), Mason Medical Research Foundation, UK and Eire Glaucoma Society.
    Publisher Copyright:
    © 2022, The Author(s).

    Keywords

    • Diseases
    • Molecular Biology
    • Molecular medicine
    • pathogenesis

    Fingerprint

    Dive into the research topics of 'Genome-wide transcriptome profiling of human trabecular meshwork cells treated with TGF-β2'. Together they form a unique fingerprint.

    Cite this